Skip to main content
Peptide Intel Hub laboratory research video
Peptide Intel Hub

Protocols · Immune

Thymalin: literature-reported ranges

Thymalin is a bovine thymic peptide extract used in Russia for decades in immune-modulation research, including long-running observational cohorts in older adults. It is a preparation rather than a defined compound.

Read this first

Every figure on this page is a range reported in published literature or in a publicly documented study protocol. It is a record of what researchers used, not a recommendation, a therapeutic protocol, or advice. Peptide Intel Hub is an independent publication, sells nothing, and describes these compounds as in-vitro research reagents only.

Compound at a glance

Class
Thymic peptide extract preparation
Reported half-life
Not characterised — it is a peptide fraction, not a single molecule
Routes used in the literature
Intramuscular in the published Russian work
Also written as

What the published studies reported

Each row below describes one body of work. The model and population are part of the figure — a rodent per-kilogram quantity and a human trial quantity are not comparable.

Russian clinical and cohort protocols

Reported quantity
10 mg per administration
Frequency
Once daily
Study duration
5–10 day courses, repeated once or twice yearly

The repeated short-course structure is consistent across this literature.

Immune-parameter studies

Reported quantity
5–20 mg per day depending on the indication studied
Frequency
Once daily
Study duration
5–14 days

T-lymphocyte subsets are the usual measured endpoint.

Mixed with 3 ml of bacteriostatic water

The same arithmetic for every vial size Thymalin is supplied in, using a fixed 3 ml of bacteriostatic water. One unit on a U-100 insulin syringe is 0.01 ml, so the unit column below is simply the volume that carries the reported amount. Educational arithmetic only — not instructions, and not medical advice.

Thymalin · 3 ml bacteriostatic water

Vial sizeConcentrationPer 1 unit
10 mg3.33 mg/ml33 mcg
100 mg33.33 mg/ml333 mcg

No single reported amount applies to this compound, so only the concentration and the value of one unit are shown. Only the vial sizes this compound is actually supplied in are shown, and every figure assumes exactly 3 ml of bacteriostatic water. For any other volume, use the reconstitution calculator.

Reconstitution maths

Supplied as a 10 mg lyophilised vial, reconstituted in 1–2 mL of sterile saline or bacteriostatic water in the source protocols.

Open the reconstitution calculator

How to read these figures

  • As an extract, batch composition is inherently variable between manufacturers.
  • Bovine-derived material carries sourcing and regulatory considerations that synthetic peptides do not.
  • The long-term cohort claims come from a single research tradition and have not been independently replicated.

Sources and citations

These are the published records the figures on this page are drawn from. Each one describes what researchers administered, in which model or population, and over what period. Quantities reported in a study are specific to that study's design and are not transferable guidance.

  1. [1]
    Peptides of pineal gland and thymus prolong human life

    Khavinson VK · Neuro Endocrinol Lett · 2002 · PMID 14523363

    Elderly patients received courses of thymic peptide bioregulator Thymalin (and pineal peptide Epithalamin) injections annually to assess effects on mortality and aging markers.

    View the record
  2. [2]
    Peptide Drug Thymalin Regulates Immune Status in Severe COVID-19 Older Patients

    Kuznik BI, Khavinson V, Shapovalov KG, et al. · Adv Gerontol · 2021 · DOI 10.1134/S2079057021040068

    Older patients with severe COVID-19 received intramuscular Thymalin injections over a defined course to evaluate immune status regulation.

    View the record
  3. [3]
    The Use of Thymalin for Immunocorrection and Molecular Aspects of Biological Activity

    Linkova NS, Chalisova NI, Ivko OM, et al. · Biol Bull Rev · 2021 · DOI 10.1134/S2079086421040046

    Review describing clinical dosing regimens (short intramuscular courses) of Thymalin used for immunocorrection in various patient populations.

    View the record

Search the databases yourself

Read the Thymalin research brief

Other immune compounds

All research protocols

Peptide Intel Hub is an independent publication and has no affiliation, ownership or commercial relationship with the suppliers listed. We sell nothing and take no payments — links are editorial references only.

Share
© 2026 Peptide Intel Hub · Marbella · Educational research reference · For in-vitro research use only
Independent publication — we sell nothing. Supplier disclosure

Peptide Intel Hub is an independent educational publication. We are not affiliated with, owned by, or the same company as Regena Peptides and Regena.app (regena-peptides.com / regena.app). We do not sell, supply, ship or take payment for any compound. Because readers regularly ask where compounds discussed in published studies can be sourced for laboratory work, we list Regena Peptides and Regena.app as suppliers we have verified and trust — every batch is released with a lot-matched third-party certificate of analysis (HPLC purity and mass-spectrometry identity). Outbound links are marked nofollow/sponsored and are provided to help readers, not to sell.